About Sparsh bio-tech
Sparsh bio-tech is a Healthcare company based in Jamnagar (India) founded in 2004. Manufacturing and exporting of pharmaceuticals, focusing on dosage forms like capsules and tablets. The company has 202 employees. Its Indian entity Sparsh Bio-Tech Private Limited reported revenue of ₹346 Cr. Sparsh bio-tech offers products and services including Amoxicillin and Ampicillin. Its focus areas include Pharmaceuticals, Drug Manufacturing, Antibiotic Formulations and Export Services.
Company details
Sparsh Bio-Tech is recognized as a pharmaceutical manufacturer and exporter based in Jamnagar, Gujarat, India, where a dedicated Betalactum plant is operated for producing dosage forms such as capsules, tablets, and dry syrups. Quality management systems are employed to ensure that medicines are developed and delivered to meet humanitarian needs, emphasizing safety, efficacy, and cost-effectiveness. The organization is noted for navigating technical and regulatory complexities in the market, while financial and logistical aspects are managed effectively to support its operations and presence in the pharmaceutical sector.
- Headquarters Jamnagar, India
- Employees 202
- SectorsHealthcare
- Email••••••••
- Website sparshbiotech.com
- Social Facebook
- Legal Name Sparsh Bio-Tech Private Limited
- Date of Incorporation 30 Mar, 2001
- Jurisdiction Jamnagar, Gujarat, India
- Annual Revenue₹346 Cr
FY 2025 · -29% YoY
- Net Profit₹11.45 Cr
FY 2025 · 3% margin
- EBITDA₹21.65 Cr
FY 2025 · 6% margin
- Employee Count202
Associated legal entities of Sparsh bio-tech
Sparsh bio-tech operates through Sparsh Bio-Tech Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Sparsh Bio-Tech Private Limited CIN U24231GJ2001PTC039373 | Active | 30 Mar 2001 | Jamnagar, Gujarat | ₹346 Cr | 202 | 4 | View details |
Products & Services of Sparsh bio-tech
Sparsh bio-tech offers a comprehensive portfolio of products and services, including Amoxicillin and Ampicillin.
Amoxicillin is produced as an antibiotic in capsule form for human health applications.
Ampicillin is manufactured as an antibiotic medication in various dosage forms.
Board of directors of Sparsh Bio-Tech Private Limited (Sparsh bio-tech)
Sparsh Bio-Tech Private Limited is the primary company behind Sparsh bio-tech. The board of Sparsh Bio-Tech Private Limited currently have 4 directors; the longest-serving is Ashok Juthalal Maru, appointed in 2001. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ashok Juthalal Maru DIN 00299779 | Managing Director | 30 Mar 2001 | 25 yrs 7 mo | Sparsh Bio-Tech Private Limited |
| Rasik Hirji Haria DIN 00300027 | Director | 03 Nov 2001 | 25 yrs | Sparsh Bio-Tech Private Limited |
| Paras Juthalal Maru DIN 00299409 | Whole-time director | 01 Apr 2003 | 23 yrs 7 mo | Sparsh Bio-Tech Private Limited |
| Sundeep Premchand Maru DIN 00299854 | Whole-time director | 30 Sep 2005 | 21 yrs 1 mo | Sparsh Bio-Tech Private Limited |
Financials of Sparsh bio-tech
Figures of Sparsh Bio-Tech Private Limited, the primary company behind Sparsh bio-tech, for FY 2025. Revenue was ₹346 Cr (-29% year on year). Net profit was ₹11.45 Cr (3% margin). EBITDA was ₹21.65 Cr (6% margin).
- ₹346 CrRevenue · FY 2025 · -29% YoY
- ₹11.45 CrNet profit · 3% margin
- ₹21.65 CrEBITDA · 6% margin
- ₹3.35 CrPaid-up capital
- 202Employees (provident fund records)
Balance sheet, profit and loss, cash flow and ratios of Sparsh Bio-Tech Private Limited are on its company page.
Detailed financial statements for Sparsh bio-tech
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Sparsh bio-tech
Sparsh bio-tech was founded in 2004.
Sparsh bio-tech is headquartered in Jamnagar, India. It is registered at Jamnagar, Gujarat, India.
Sparsh bio-tech has 202 employees.
The primary company behind Sparsh bio-tech, Sparsh Bio-Tech Private Limited, reported revenue of ₹346 Cr for FY 2025, down 29% year on year.
Sparsh Bio-Tech is recognized as a pharmaceutical manufacturer and exporter based in Jamnagar, Gujarat, India, where a dedicated Betalactum plant is operated for producing dosage forms such as capsules, tablets, and dry syrups. Quality management systems are employed to ensure that medicines are developed and delivered to meet humanitarian needs, emphasizing safety, efficacy, and cost-effectiveness. The organization is noted for navigating technical and regulatory complexities in the market, while financial and logistical aspects are managed effectively to support its operations and presence in the pharmaceutical sector.
Sparsh bio-tech offers Amoxicillin and Ampicillin.
Sparsh bio-tech operates through Sparsh Bio-Tech Private Limited.
The legal entities of Sparsh bio-tech currently have 4 directors, including Rasik Hirji Haria, Ashok Juthalal Maru, Sundeep Premchand Maru and others.